Development and study of the effectiveness of a biologically active drug in the diet of sows

Abstract

Many researchers note the need to improve feed additives and the search for new promising drugs for the intensification of the pig industry. We have developed a biologically active complex drug Microlact. It is used by animals as a means aimed at correcting the disturbed metabolism of sows associated with pregnancy and lactation, to activate the growth and development of piglets as well as their viability. The purpose of the work was to develop and study the effectiveness of the biologically active drug in the diet of lactating sows. The use of the drug led to the improvement of biochemical parameters of blood of pregnant sows, indicating the activation of metabolic processes in their body, which provided the increase in milk yield of sows, average daily weight gain of piglets and their livability. The live weight of piglets for weaning increased by 8,0% (P < 0,01), the livability of suckling piglets increased to 93,1%, which is a consequence of improving the quality of colostrum and milk, and consequently the positive effect of the biologically active drug containing an optimal complex of minerals, vitamin E in the composition of malt sprouts, essential amino acids and organic form of selenium. More nutritious colostrum and milk contributed to the better development of the piglets’ body and resistance to adverse factors. Immunoglobulins have been obtained by piglets with colostrum and milk increase their resistance and contribute to higher livability. The increase in the weight of suckling pigs has a positive effect on the further development and growth of animals on fattening. Thus, the administration of the biologically active drug Microlact to sows during pregnancy leads to the activation of metabolic processes, which can only be provided by a high level of functioning of the organs and systems of the body.